PAT EMILIE POLIMENI: Open Payments
NPI 1174111215 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,423 in 124 payments from 24 companies in 2025. Trend: 2023 $35 · 2024 $1,786 · 2025 $2,423
Food & beverage: $2,423
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 24 | $481 |
| PFIZER INC. | 17 | $364 |
| Otsuka America Pharmaceutical, Inc. | 20 | $222 |
| Lilly USA, LLC | 12 | $214 |
| Axsome Therapeutics, Inc. | 11 | $200 |
| Celgene Corporation | 10 | $186 |
| Genentech USA, Inc. | 5 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
Products named: VYEPTI, NURTEC ODT, REXULTI, Symbravo, ZEPOSIA, KISUNLA, Ocrevus Zunovo, KESIMPTA.
Industry payments across NY — which companies pay providers there.
